Envista Holdings (NVST) | Financial Analysis & Statements
Envista Holdings Corporation Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
750.6M
Gross Profit
410.6M
54.70%
Operating Income
93.0M
12.39%
Net Income
32.9M
4.38%
EPS (Diluted)
$0.20
Balance Sheet Metrics
Total Assets
5.7B
Total Liabilities
2.6B
Shareholders Equity
3.1B
Debt to Equity
0.83
Cash Flow Metrics
Operating Cash Flow
70.4M
Free Cash Flow
91.7M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Envista Holdings Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.7B | 2.5B | 2.6B | 2.6B | 2.5B |
| Cost of Goods Sold | 1.2B | 1.1B | 1.1B | 1.1B | 1.1B |
| Gross Profit | 1.5B | 1.4B | 1.4B | 1.5B | 1.4B |
| Gross Margin % | 54.7% | 54.7% | 56.1% | 57.4% | 56.9% |
| Operating Expenses | |||||
| Research & Development | 114.0M | 99.1M | 93.8M | 100.1M | 100.5M |
| Selling, General & Administrative | 1.1B | 1.1B | 1.1B | 1.1B | 1.0B |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 1.3B | 1.2B | 1.2B | 1.2B | 1.1B |
| Operating Income | 235.8M | 137.2M | 289.8M | 319.2M | 306.2M |
| Operating Margin % | 8.7% | 5.5% | 11.3% | 12.4% | 12.2% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 36.6M | 46.4M | 63.4M | 38.4M | 54.1M |
| Other Non-Operating Income | -22.0M | -1.2B | -281.3M | 3.1M | 2.4M |
| Pre-tax Income | 177.2M | -1.1B | -54.9M | 283.9M | 254.5M |
| Income Tax | 130.2M | 33.9M | 45.3M | 45.9M | -9.0M |
| Effective Tax Rate % | 73.5% | 0.0% | 0.0% | 16.2% | -3.5% |
| Net Income | 47.0M | -1.1B | -100.2M | 243.1M | 340.5M |
| Net Margin % | 1.7% | -44.6% | -3.9% | 9.5% | 13.6% |
| Key Metrics | |||||
| EBITDA | 384.2M | 291.6M | 429.4M | 484.4M | 460.5M |
| EPS (Basic) | - | $-6.50 | $-0.60 | $1.49 | $2.11 |
| EPS (Diluted) | - | $-6.50 | $-0.60 | $1.37 | $1.92 |
| Basic Shares Outstanding | - | 172200000 | 166900000 | 162900000 | 161200000 |
| Diluted Shares Outstanding | - | 172200000 | 166900000 | 162900000 | 161200000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Envista Holdings Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 1.2B | 1.1B | 940.0M | 606.9M | 1.1B |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 429.6M | 363.0M | 407.5M | 393.5M | 331.9M |
| Inventory | 288.1M | 241.0M | 258.8M | 300.8M | 263.8M |
| Other Current Assets | 97.2M | 115.2M | 137.4M | 123.4M | 154.3M |
| Total Current Assets | 2.0B | 1.8B | 1.7B | 1.4B | 1.8B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 142.1M | 142.8M | 125.1M | 131.8M | 128.1M |
| Goodwill | 5.3B | 5.2B | 7.5B | 8.1B | 7.3B |
| Intangible Assets | 627.2M | 649.9M | 954.0M | 1.1B | 1.0B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 228.1M | 230.6M | 180.5M | 153.7M | 167.8M |
| Total Non-Current Assets | 3.7B | 3.6B | 4.9B | 5.2B | 4.7B |
| Total Assets | 5.7B | 5.4B | 6.6B | 6.6B | 6.6B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 191.6M | 174.6M | 179.5M | 228.3M | 185.8M |
| Short-term Debt | 39.0M | 150.5M | 145.6M | 537.0M | 456.1M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 97.6M | 86.9M | 84.6M | 84.7M | 157.9M |
| Total Current Liabilities | 852.6M | 878.7M | 780.8M | 1.2B | 1.2B |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.6B | 1.4B | 1.5B | 992.1M | 1.0B |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 12.0M | 3.6M | 7.8M | 10.2M | 6.6M |
| Total Non-Current Liabilities | 1.7B | 1.5B | 1.7B | 1.1B | 1.3B |
| Total Liabilities | 2.6B | 2.4B | 2.4B | 2.4B | 2.5B |
| Equity | |||||
| Common Stock | 1.8M | 1.7M | 1.7M | 1.6M | 1.6M |
| Retained Earnings | -440.4M | -487.4M | 631.2M | 731.4M | 466.9M |
| Treasury Stock | 224.5M | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 3.1B | 2.9B | 4.2B | 4.2B | 4.1B |
| Key Metrics | |||||
| Total Debt | 1.6B | 1.5B | 1.7B | 1.5B | 1.5B |
| Working Capital | 1.2B | 909.6M | 962.9M | 187.9M | 627.6M |
Balance Sheet Composition
Envista Holdings Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 47.0M | -1.1B | -100.2M | 243.1M | 340.5M |
| Depreciation & Amortization | 150.7M | 154.5M | 162.6M | 162.1M | 151.9M |
| Stock-Based Compensation | 37.6M | 35.3M | 30.7M | 30.5M | 28.2M |
| Working Capital Changes | -114.8M | -59.4M | -99.7M | -127.0M | -226.0M |
| Operating Cash Flow | 136.1M | -983.3M | 27.8M | 327.0M | 328.7M |
| Investing Activities | |||||
| Capital Expenditures | -44.8M | -33.7M | -52.1M | -72.4M | -43.1M |
| Acquisitions | 0 | 400.0K | 10.7M | -622.3M | 310.4M |
| Investment Purchases | -9.9M | -32.8M | - | - | - |
| Investment Sales | 10.4M | 11.8M | 1.6M | 56.0M | 11.4M |
| Investing Cash Flow | -51.1M | -54.6M | -62.4M | -657.3M | 262.7M |
| Financing Activities | |||||
| Share Repurchases | -166.6M | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 0 | 0 | 823.7M | 300.0K | 0 |
| Debt Repayment | -116.3M | -100.0M | -690.0M | -124.5M | -475.7M |
| Financing Cash Flow | -173.7M | -106.1M | 107.6M | -133.3M | -485.1M |
| Free Cash Flow | 230.4M | 302.7M | 217.5M | 107.0M | 306.9M |
| Net Change in Cash | -88.7M | -1.1B | 73.0M | -463.6M | 106.3M |
Cash Flow Trend
Envista Holdings Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
96.57
Forward P/E
17.35
Price to Book
1.43
Price to Sales
1.62
PEG Ratio
0.05
Profitability Ratios
Profit Margin
1.73%
Operating Margin
10.74%
Return on Equity
1.56%
Return on Assets
2.78%
Financial Health
Current Ratio
2.38
Debt to Equity
51.43
Beta
0.98
Per Share Data
EPS (TTM)
$0.28
Book Value per Share
$18.96
Revenue per Share
$16.19
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| NVST | 4.4B | 96.57 | 1.43 | 1.56% | 1.73% | 51.43 |
| Intuitive Surgical | 170.1B | 54.97 | 8.99 | 16.69% | 28.38% | 0.95 |
| Becton, Dickinson | 56.1B | 25.40 | 1.75 | 6.96% | 8.01% | 77.28 |
| Baxter International | 9.4B | 86.31 | 1.54 | -13.71% | -8.51% | 160.28 |
| AptarGroup | 8.0B | 21.10 | 2.99 | 15.10% | 10.40% | 57.10 |
| Repligen | 7.5B | 154.30 | 3.55 | 2.40% | 6.62% | 32.76 |
Financial data is updated regularly. All figures are in the company's reporting currency.






